Diagnostic Errors Are Common in Seriously Ill Hospitalized Adults
A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.
New CRISPR Center Brings Hope for Rare and Deadly Genetic Diseases
The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic disorders that have no cure, to ensure treatments can be developed and brought to patients more quickly and efficiently.
Could a Drug Prevent Hearing Loss from Loud Music and Aging?
A newly-discovered gene may explain how humans go deaf both as they age, and in response to loud noise.
How Fruit Bats Got a Sweet Tooth Without Sour Health
Fruit bats have a genetic system that controls blood sugar without fail. Learning from that system can help us make better insulin- or sugar-sensing therapies for human patients.
Survey Shows Physicians Don’t Understand FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).
Physicians said they wanted to see more rigorous pre-market evidence, as well as regulatory action against drugs and devices that do not demonstrate safety and effectiveness after they have been approved for use.
Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found that a higher proportion of individuals than previously reported experience rebounds after taking Paxlovid.
The study appears Jan. 4, 2024, in the Journal of Medical Virology.
For Dementia Prevention, Sleep Quality in Midlife Matters More
Quality of sleep, not quantity, may play a part in the development of dementia decades before symptoms start.